Thompson Hine advised Palatin Technologies, while Sullivan & Worcester advised the placement agents on the offering. Palatin Technologies, Inc. (NYSE: PTN) announced a $4.7 million registered...
You must be a Standard 1 Year member to access this content.
Thompson Hine represented Stardust Power, Inc., while Sullivan & Worcester represented A.G.P./Alliance Global Partners in the offering. Stardust Power Inc. (Nasdaq: SDST) completed its $5.75 million...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester was placement agent’s counsel for A.G.P./Alliance Global Partners and Maxim Group LLC in connection with the offering. SELLAS Life Sciences Group, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Jones Day acted as counsel for Cibus, while Sullivan & Worcester acted as counsel for A.G.P./Alliance Global Partners in the offering. Cibus, Inc. (Nasdaq: CBUS) announced...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Intensity Therapeutics, while Sullivan & Worcester advised the placement agents in the offering. Intensity Therapeutics, Inc. (Nasdaq: INTS)...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. Palladyne AI Corp. (Nasdaq: PDYN and PDYNW), a developer of artificial intelligence software for robotic platforms...
You must be a Standard 1 Year member to access this content.
Locke Lord advised Professional Diversity Network, while Sullivan & Worcester represented A.G.P./Alliance Global Partners in the offering. Professional Diversity Network, Inc. (NASDAQ: IPDN) has entered into...
You must be a Standard 1 Year member to access this content.
Dorsey & Whitney advised Shuttle Pharmaceuticals, while Sullivan & Worcester advised A.G.P./Alliance Global Partners in the offering. Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) announced the pricing...
You must be a Standard 1 Year member to access this content.
ArentFox Schiff advised CNS Pharmaceuticals, while Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. CNS Pharmaceuticals, Inc. closed the $3 million registered direct offering...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester represented A.G.P./Alliance Global Partners in the transaction. XORTX Therapeutics has entered into securities purchase agreements with institutional investors for the purchase and sale...
You must be a Standard 1 Year member to access this content.
Jones Day represented Cibus, while Sullivan & Worcester represented ROTH Capital Partners and A.G.P./Alliance Global Partners on the offering. Cibus, Inc. (Nasdaq: CBUS) announced the public...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised BioCardia, while Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. BioCardia, Inc. (Nasdaq: BCDA) completed its $7.2 million...
You must be a Standard 1 Year member to access this content.
